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Coccidioides immitis is a pathogenic fungus populating the southwestern United
States and is a causative agent of coccidioidomycosis, sometimes referred to as
Valley Fever. Although the genome of this fungus has been sequenced, many
operons are not properly annotated. Crystal structures are presented for a
putative uncharacterized protein that shares sequence similarity with  -class
glutathione S-transferases (GSTs) in both apo and glutathione-bound forms.
The apo structure reveals a nonsymmetric homodimer with each protomer
comprising two subdomains: a C-terminal helical domain and an N-terminal
thioredoxin-like domain that is common to all GSTs. Half-site binding is
observed in the glutathione-bound form. Considerable movement of some
components of the active site relative to the glutathione-free form was observed,
indicating an induced-ﬁt mechanism for cofactor binding. The sequence
homology, structure and half-site occupancy imply that the protein is a  -class
glutathione S-transferase, a maleylacetoacetate isomerase (MAAI).
1. Introduction
Glutathione S-transferases (GSTs) are detoxifying enzymes that
appear across a wide range of aerobic organisms, including bacteria,
fungi, plants and mammals. This enzyme superfamily conjugates
toxins with glutathione and the conjugate is then eliminated from
the organism. Trimeric membrane-bound and dimeric cytosolic GSTs
have been described, although they do not appear to share sequence
or structural similarities (Hayes & Pulford, 1995). All cytosolic GSTs
share a common fold (       , related to thioredoxin) and they are
divided into a number of different classes ( ,  , !,  ,  ,   etc.) based
on sequence analysis (Snyder & Maddison, 1997). Crystal structures
have been determined for all major classes of GSTs (Dirr et al., 1994;
Sheehan et al., 2001). These structures reveal a G-site where gluta-
thione binds and an H-site where the hydrophobic substrate binds.
Many organisms contain multiple GST isoforms that recognize
different or occasionally overlapping substrates (Mannervik et al.,
1992). Human  -class GSTs are overexpressed in many cancers
and are thought to be potential drug targets (Federici et al., 2009;
Quesada-Soriano et al., 2011). In plants, GSTs are often associated
with herbicide resistance (Prade et al., 1998). In insects such as the
mosquito that may be a carrier of malaria, GSTs are associated with
insecticide resistance (Oakley et al., 2001).
The Seattle Structural Genomics Center for Infectious Disease
(SSGCID) is a structural genomics consortium dedicated to protein
structure elucidation from National Institute for Allergy and Infec-
tious Diseases (NIAID) class A–C organisms, with an emphasis on
underserved and re-emerging pathogens (Myler et al., 2009). One
major goal is to provide a blueprint for structure-guided drug design
by determining the three-dimensional structures of potential drug
targets (Van Voorhis et al., 2009). One target organism is Coccidioides
immitis, a dust-borne pathogenic fungus that, along with the closely
related species C. posadasii, causes coccidioidomycoses (Hector &
Laniado-Laborin, 2005). C. immitis-related coccidioidomycosis is also
known as Valley Fever because the disease is highly endemic in the
San Joaquin Valley in California, USA. In addition, coccidioido-mycosis is endemic in semiarid regions of the southwestern United
States, Mexico and parts of South America (Hector & Laniado-
Laborin, 2005). Many C. immitis infections resolve spontaneously,
although the infection is sometimes fatal, especially in immuno-
compromised patients or patients with disseminated and central
nervous system illnesses (Deus Filho, 2009). Existing therapies are
relatively ineffective and new therapeutic options are needed (Hector
& Laniado-Laborin, 2005). The genome of C. immitis has been
sequenced (Sharpton et al., 2009), although many of the open reading
frames have been annotated as putative uncharacterized proteins. At
the start of the SSGCID project in September 2007, the Protein Data
Bank (PDB) only contained structures of one C. immitis protein: a
chitinase (Bortone et al., 2002; Hollis et al., 2000).
Here, we report the structural characterization of one C. immitis
gene product originally annotated as a ‘putative uncharacterized
protein’. This protein (UniProt accession code D2YW48; formerly
Q1E7Z9) has sequence homology to  -class GSTs of known structure
and 98% sequence identity to a C. posadasii putative maleylaceto-
acetate isomerase (MAAI; UniProt entry C5PGS4; Sharpton et al.,
2009). We determined a 2.2 A ˚ resolution apo crystal structure of the
C. immitis D2YW48 gene product by molecular replacement using
the mouse  -class GST (PDB entry 2cz2; E. Mizohata, S. Morita,
Y. Kinoshita, K. Nagano, H. Uda, T. Uchikubo, M. Shirouzu & S.
Yokoyama, unpublished work) as a search model. In addition, we
obtained a 1.85 A ˚ resolution crystal structure of the D2YW48 gene
product bound to glutathione in one half-site. In combination, the
genomic sequence-similarity data, the apo structural fold and the
half-site glutathione binding imply that the D2YW48 gene product is
likely to be a  -class GST.
2. Methods
2.1. Protein expression and purification
The 231-residue C. immitis hypothetical protein gene (UniProt
accession code D2YW48, formerly Q1E7Z9; XP_001247543) was
ampliﬁed from genomic DNA and cloned into an expression vector
(pAVA0421) encoding an N-terminal histidine-afﬁnity tag followed
by the human rhinovirus 3C protease cleavage sequence (the entire
tag sequence is MAHHHHHHMGTLEAQTQGPGS, followed by
the 231-residue C. immitis GST) using ligation-independent cloning
(Aslanidis & de Jong, 1990). The clone was transformed into
Escherichia coli BL21 (DE3) R3 Rosetta cells. Starter cultures of LB
broth with appropriate antibiotics were grown for  18 h at 310 K.
ZYP-5052 auto-induction medium was prepared as described by
Studier (2005). The protein was expressed in a LEX bioreactor in
the presence of antibiotics in 2 l sterilized auto-induction medium
inoculated with the overnight starter culture. After 24 h at 298 K the
temperature was reduced to 288 K for a further 60 h. The sample was
centrifuged at 4000g for 20 min at 277 K. The cell paste was ﬂash-
frozen in liquid nitrogen and stored at 193 K. The frozen cells were
resuspended in 25 mM HEPES pH 7.0, 500 mM NaCl, 5%(v/v)
glycerol, 0.5% CHAPS, 30 mM imidazole, 10 mM MgCl2,1 m M
TCEP, 250 mgm l
 1 AEBSF and 0.025%(w/v) azide at 277 K. Lysis
was achieved by sonication followed by incubation with Benzonase
(20 ml at 25 units per microlitre). Insoluble proteins and other cellular
components were removed by centrifugation at 14 000 rev min
 1 for
75 min at 277 K. The soluble fraction was then loaded onto an Ni–
NTA His-Trap FF 5 ml column (GE Healthcare). The column was
washed with 20 column volumes of wash buffer [25 mM HEPES pH
7.0, 500 mM NaCl, 5%(v/v) glycerol, 30 mM imidazole, 1 mM TCEP
and 0.025%(w/v) azide]. The bound protein was eluted with seven
column volumes of elution buffer [25 mM HEPES pH 7.0, 500 mM
NaCl, 5%(v/v) glycerol, 1 mM TCEP, 250 mM imidazole and
0.025%(w/v) azide]. Cleavage of the N-terminal His tag was accom-
plished by dialysis with His-MBP-3C protease at 277 K overnight in
25 mM HEPES pH 7.5, 500 mM NaCl, 5%(v/v) glycerol, 1 mM TCEP
and 0.025%(w/v) azide. The cleaved protein was recovered in the
ﬂowthrough and wash fractions of a subtractive Ni
2+-afﬁnity chro-
matography step that removed His-MBP-3C protease, uncleaved
protein and the cleaved His tag. The collected cleaved protein
(sequence GPGS followed by the 231-residue C. immitis GST) was
loaded onto a HiLoad 26/60 Superdex 75 prep-grade column (GE
Healthcare) equilibrated in 25 mM HEPES pH 7.0, 500 mM NaCl,
5%(v/v) glycerol, 2 mM dithiothreitol and 0.025%(w/v) azide. SDS–
PAGE was used to determine fractions to pool. The puriﬁed protein
was concentrated to 23.9 mg ml
 1 and stored at 193 K.
2.2. Crystallization
Crystallization trials were set up according to a rational crystal-
lization approach (Newman et al., 2005) using the JCSG+ and PACT
sparse-matrix screens from Emerald BioSystems and Molecular
Dimensions. In addition, crystallization trials were set up with the
Index and Crystal Screen HT sparse-matrix screens from Hampton
Research. 0.4 ml protein solution at 23.9 mg ml
 1 in 25 mM HEPES
pH 7.0, 0.5 M NaCl, 5%(v/v) glycerol, 2 mM dithiothreitol and
0.025%(w/v) azide and an equal volume of precipitant were
equilibrated against 80 ml reservoir solution at 289 K in sitting-drop
vapor-diffusion format in 96-well Compact Jr plates from Emerald
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Table 1
Data-collection statistics.
Values in parentheses are for the highest of 20 resolution shells.
Ligand Apo Glutathione
Space group P212121 C2221
Unit-cell parameters (A ˚ ) a = 51.7, b = 99.6,
c = 184.4
a = 49.6, b = 110.9,
c = 168.5
Wavelength (A ˚ ) 1.000 1.5418
Resolution range (A ˚ ) 50–2.20 (2.24–2.20) 50–1.85 (1.90–1.85)
No. of unique reﬂections 49300 39710
Multiplicity 6.8 (6.0) 5.5 (1.9)
Completeness (%) 99.7 (97.9) 98.8 (88.5)
Rmerge† 0.121 (0.529) 0.072 (0.359)
Mean I/ (I) 13.2 (4.8) 17.8 (2.3)
† Rmerge =
P
h
P
i jIiðhÞ h IðhÞij=
P
h
P
i IiðhÞ.
Table 2
Reﬁnement and model statistics.
Values in parentheses are for the highest of 20 resolution shells.
Ligand Apo Glutathione
Resolution range (A ˚ ) 50–2.20 (2.26–2.20) 50–1.85 (1.90–1.85)
Rcryst† 0.173 (0.252) 0.160 (0.247)
Rfree† 0.226 (0.285) 0.205 (0.306)
R.m.s.d. bonds (A ˚ ) 0.015 0.015
R.m.s.d. angles ( ) 1.463 1.377
Protein atoms 6845 3409
Hetero atoms 20 35
Waters 590 460
Mean B factor (A ˚ 2) 23.4 15.9
Glutathione B factor (A ˚ 2) — 20.0
Residues in favored region (%) 99.1 99.5
Residues in allowed region (%) 99.1 100
MolProbity‡ score [percentile] 1.23 [100th] 1.24 [99th]
PDB code 3lg6 3n5o
† Rfree =
P
hkl
   jFobsj j Fcalcj
   =
P
hkl jFobsj. The free R factor was calculated using 5% of
the reﬂections, which were omitted from the reﬁnement (Winn et al., 2011). ‡ Chen et
al. (2010), Davis et al. (2007).BioSystems. Within a week, apocrystals grew in the presence of 0.2 M
lithium sulfate, 0.1 M Tris pH 8.5 and 30% PEG 4000 (Crystal Screen
HT condition No. 17). Another protein sample was incubated with
10 mM reduced glutathione and crystallization trials were set up as
above. Crystals grew within a week in the presence of 0.2 M ammo-
nium sulfate and 30% PEG 8000 (Crystal Screen HT condition
No. 30).
2.3. Data collection and structure determination
Both apo and glutathione-containing protein crystals were
harvested, cryoprotected with a solution consisting of the precipitant
supplemented with 25% ethylene glycol and vitriﬁed in liquid
nitrogen. A data set was collected at 100 K from an apo crystal under
a stream of liquid nitrogen on the Advanced Light Source (ALS)
beamline 5.0.2 as part of the ALS Collaborative Crystallography
program (Table 1). A data set was collected from a glutathione-
containing crystal at 100 K under a stream of liquid nitrogen using a
Rigaku FR-E
+ SuperBright X-ray generator with Osmic VariMax
optics and a Saturn 944+ detector (Table 1). Data were reduced with
XDS/XSCALE (Kabsch, 2010). The apo structure (Table 2) was
solved by molecular replacement using the mouse  -class GST
monomer (PDB entry 2cz2; E. Mizohata, S. Morita, Y. Kinoshita,
K. Nagano, H. Uda, T. Uchikubo, M. Shirouzu & S. Yokoyama,
unpublished work) as a search model in Phaser (McCoy et al., 2007)
from the CCP4 suite (Winn et al., 2011). The structure was rebuilt
using ARP/wARP (Langer et al., 2008). The glutathione-bound
structure (Table 2) was solved by molecular replacement using the
apo structure as a search model in Phaser (McCoy et al., 2007). The
ﬁnal models were obtained after numerous rounds of reﬁnement in
REFMAC (Murshudov et al., 1997) and manual rebuilding in Coot
(Emsley & Cowtan, 2004). Structures were assessed for correctness
and validated using MolProbity (Davis et al., 2007; Chen et al., 2010).
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Figure 1
The 2.2 A ˚ resolution apo crystal structure of a previously uncharacterized protein
and putative  -class GST from C. immitis shown in cartoon representation. The
thioredoxin-like domain (       ) is shown with  -helices in red,  -sheets in
yellow and loops in green. The  -helical domain is shown in blue. The sulfate ion in
the H-site is shown in stick representation. All ﬁgures were prepared with PyMOL
(DeLano, 2002).
Figure 2
(a) Overlay of the 2.2 A ˚ resolution apo crystal structure of a putative  -class GST
from C. immitis in gray with a 1.85 A ˚ resolution glutathione-bound structure in
green. Glutathione and sulfate ions are shown in stick representation. An unbiased
OMIT map (|Fo|   |Fc|) is shown in green mesh contoured at 2.5 .( b) Close-up of
the overlay shown in (a) showing the large-scale movement of  2 and loops upon
glutathione binding. (c) Interactions of glutathione (GSH) with G-site residues. All
residues other than Asp1220 are from the same protomer.3. Results and discussion
3.1. Apo structure
The putative uncharacterized protein from C. immitis (UniProt ID
D2YW48) investigated here contains 231 residues. The 2.2 A ˚ reso-
lution apostructure contains twopseudosymmetrically related dimers
in the asymmetric unit. Each protomer consists of an N-terminal
        thioredoxin-like fold common to all GSTs as well as a
C-terminal  -helical domain (Fig. 1). The C. immitis protein exhibits
a nonsymmetrical dimer in which one protomer has several more
ordered residues than the other; residues 39–52 are disordered in the
second protomer. These residues correspond to the cap of the active
site and coordinate glutathione in the G-site (see below).
All four chains in the asymmetric unit contain a sulfate molecule
that binds to the backbone N atom and side-chain hydroxyl of Ser15
as well as the side chain of Gln124 and forms water-mediated inter-
actions with several additional residues. A sulfate ion is observed in
approximately the same orientation off Ser15 as in the H-site of the
human  -class GST crystal structure (Polekhina et al., 2001) and is
believed to simulate the expected binding of the substrate dichloro-
acetic acid (Ricci et al., 2004). In the human GSTZ1-1 crystal struc-
ture the sulfate ion is also coordinated by Arg175. The equivalent
Arg190 in the C. immitis structure resides in a different rotomer
conformation without forming interactions with the sulfate ion
(which is approximately 4.8 A ˚ away in each protomer); it is involved
in salt-bridge interactions within the crystal lattice.
3.2. Glutathione-bound structure
A1 . 8 5A ˚ resolution crystal structure was determined from a crystal
grown in the presence of 10 mM glutathione ( 10.7 equivalents
relative to protein at 0.93 mM). The structure was of a different
crystal form to the apo structure and contained one dimer in the
asymmetric unit. This structure revealed the presence of glutathione
in one protomer, again revealing a nonsymmetrical dimer (Fig. 2).
The position of glutathione is almost identical to that observed in
human GSTZ1-1 (Polekhina et al., 2001) and forms interactions with
the conserved residues Ser14, Gln43, Gln80, Ser81, Asp1220 (from the
other protomer), Gln124 and Asn128 (Fig. 2c). The distance between
the Cys16 S atom and the glutathione S atom was 3.7 A ˚ . Similarly,
the distance between these atoms was 2.8 A ˚ in the human GSTZ1-1
crystal structure, indicating the lack of a disulﬁde bond (Polekhina et
al., 2001). A sulfate ion was observed in the same position off Ser14 as
in the apo crystal structure, again with Arg190 positioned away from
the sulfate ion (4.6 A ˚ ). The glutathione-bound protomer was ordered
from residues 3 to 230, whereas the other unliganded protomer was
ordered from residues 3 to 39 and residues 55 to 231. Furthermore,  2
and the residues that surround the glutathione moved signiﬁcantly
relative to the apo structure (r.m.s.d. of 0.77 A ˚ for all residues, but in
the range 1.9–7.0 A ˚ for residues 42–56; Fig. 2b), which is indicative of
an induced-ﬁt mechanism for cofactor binding.
3.3. Comparison with other GSTs
The C. immitis protein investigated here shares sequence homo-
logy with several  -class GSTs of known structure, speciﬁcally human
(Homo sapiens, 44% sequence identity; Polekhina et al., 2001), mouse
(Mus musculus, 44% sequence identity; E. Mizohata, S. Morita,
Y. Kinoshita, K. Nagano, H. Uda, T. Uchikubo, M. Shirouzu & S.
Yokoyama, unpublished work), a plant (Arabidopsis thaliana, 36%
sequence identity; Thom et al., 2001) and a bacterium (Ralstonia sp.,
35% sequence identity; Marsh et al., 2008). The C. immitis structure
overlays remarkably well with the human GSTZ1-1 (r.m.s.d. 0.95 A ˚ ),
mouse GSTZ (r.m.s.d. 1.01 A ˚ ), A. thaliana GSTZ (r.m.s.d. 1.42 A ˚ )
and Ralstonia GSTZ (r.m.s.d. 1.06 A ˚ ) structures (Fig. 3a); super-
position calculations were performed using the CCP4 suite (Winn
et al., 2011). Despite clearly sharing the same thioredoxin-like fold
(Fig. 3b), the C. immitis structure has such weak sequence homology
to other classes of GST (typically <10% over the full protein
sequence) that its structure overlays poorly with these classes. For
structural communications
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Figure 3
(a) Overlay of the crystal structures of a putative  -class GST from C. immitis
shown in gray with human  -class GST in light blue (with glutathione and sulfate
ion shown as sticks; Polekhina et al., 2001) and mouse  -class GST in dark blue
(Mizohata et al., unpublished work). (b) Overlay of the crystal structures of a
putative  - class GST from C. immitis shown in gray with human  -class GSTP1-1 in
pink [with GST and the inhibitor 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol
(NBDHEX) in stick representation; Federici et al., 2009] and human  -class
GSTT1-1 in dark red (Tars et al., 2006).example, human   GST 1-1 (PDB entry 3gus; Federici et al., 2009)
overlays with an r.m.s.d. of 2.53 A ˚ , human   GST 1-1 (PDB entry
2c3q; Tars et al., 2006) overlays with an r.m.s.d. of 2.22 A ˚ and human  
GST (PDB entry 1yxz; Li et al., 2005) overlays with an r.m.s.d. of
2.93 A ˚ .
In the C. immitis structure glutathione is bound in only one half-
site. This is consistent with binding studies on human GSTZ1-1, which
showed half-site glutathione binding even at saturating glutathione
concentrations and are suggestive of a cooperative mechanism (Ricci
et al., 2004). Interestingly, the crystal structure of human GSTZ1-1
bound to glutathione (Polekhina et al., 2001) contains only one
molecule in the asymmetric unit, with the other protomer being
generated by crystallographic symmetry, indicating that the two
protomers are identical. Similarly, the crystal structures of the
Ralstonia  -class GST (Marsh et al., 2008) show glutathione or a
glutathione conjugate bound in both protomers. Thus, it appears that
the crystal structures and solution-based binding studies of  -class
GSTs are not always in agreement on half-site or full-site glutathione
binding.
The C. immitis crystal structure contains an asparagine-rich and
serine-rich loop between  3 and  4 (residues 64–74) that is not
present in other  -class GST crystal structures (Figs. 1 and 3). This
loop interacts almost exclusively with the other protomer and
therefore may stabilize dimer formation or be involved in recognition
of another protein or some other as yet undiscovered function.
One of the deﬁning characteristics of  -class GSTs is the high
sequence conservation of  1, which contains the sequence SSCS(H/
W)RVRAIL (Board et al., 1997). The equivalent residues of the
C. immitis protein contain three single point differences (SSCSGR-
LRAIF) yet retain a highly similar backbone structure (Fig. 4). Two
of these are conservative differences. The nonconserved difference
at residue 18 is the presence of a glycine residue where there is
normally a histidine or tryptophan residue. However, the C. immitis
structure reveals a tryptophan residue at position 186 that ﬁlls the
pocket generated by the lack of a side chain at Gly18; the equivalent
position in human or mouse GSTZ1-1 is Ala171 (Fig. 4). Thus, the
C. immitis protein contains a compensating amino-acid change that
allows it to retain a highly similar  1 structure.
4. Conclusions
 -Class GSTs have been identiﬁed across a wide range of organisms
(Board & Anders, 2005; Board et al., 1997). Here, we report two
crystal structures of a putative uncharacterized protein from
C. immitis, the pathogenic fungus that causes coccidioidomycosis.
Based on sequence homology, structural similarity, half-site gluta-
thione binding and sulfate ion H-site binding, the protein investigated
here is likely to be a  -class GST/MAAI. The next step is to deter-
mine the actual enzymatic activity of the protein and identify its
substrates. To address this, we plan to investigate the binding of this
C. immitis GST to a wide variety of commercially available gluta-
thione conjugates as well as dichloroacetate, which has been
described as a suicide inhibitor of GSTZ/MAAI (Ricci et al., 2004;
Stacpoole, 2011). Such investigations will be reported in due course.
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